Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT

DSpace/Manakin Repository

Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT
 
Adams, Hugo J.A.; de Klerk, John M. H.; Regelink, Josien C.; Heggelman, Ben G. F.; Dubois, Stefan V.; Kwee, Thomas C.
(2017) Nuclear Medicine and Molecular Imaging, volume 51, issue 4, pp. 371 - 373
(Article)
Abstract
A 22-year-old woman was diagnosed with intermediate risk stage II Hodgkin lymphoma and treated with three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by involved-field radiation therapy. A complete metabolic remission was achieved after two cycles of ABVD, which was maintained until three years after completion of treatment. ... read more
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Biopsy, FDG-PET/CT, Giant cell granuloma, Hodgkin lymphoma, Radiology Nuclear Medicine and imaging, Journal Article
DOI: https://doi.org/10.1007/s13139-016-0426-9
ISSN: 1869-3474
Publisher: Springer Verlag
Note: Funding Information: We thank the Netherlands Committee on Bone Tumors for assistance in interpreting the histopathological slides. This manuscript has not been published before or is not under consideration for publication anywhere else and has been approved by all co-authors. Hugo J.A. Adams: no conflict of interest. John M.H. de Klerk: no conflict of interest. Josien C. Regelink: no conflict of interest. Ben. G.F. Heggelman: no conflict of interest. Stefan V. Dubois: no conflict of interest. Thomas C. Kwee; no conflict of interest. This work was financially supported by an Alpe d’HuZes/Dutch Cancer Society Bas Mulder Award for T.C.K. (grant number 5409). Data collection, data analysis, and interpretation of data, writing of the paper, and decision to submit were left to the authors’ discretion and were not influenced by Alpe d’HuZes/Dutch Cancer Society. Funding Information: Funding This work was financially supported by an Alpe d’HuZes/Dutch Cancer Society Bas Mulder Award for T.C.K. (grant number 5409). Data collection, data analysis, and interpretation of data, writing of the paper, and decision to submit were left to the authors’ discretion and were not influenced by Alpe d’HuZes/Dutch Cancer Society. Publisher Copyright: © 2016, Korean Society of Nuclear Medicine.
(Peer reviewed)